Sebastiaan Veersema

ORCID: 0000-0002-9264-4908 · 4 papers in corpus
article 2024
Waste analysis and energy use estimation during MR-HIFU treatment: first steps towards calculating total environmental impact
·doi:10.1186/s13244-024-01655-2

OBJECTIVES: (carbon dioxide) emission from the MRI scanner, MR-HIFU device, and the medication used, and analyzed solid waste produced during treatment. METHODS: emission based on the energy used by the MRI scanner and MR-HIFU device and th…

2021
Comparison of (Cost-)Effectiveness of Magnetic Resonance Image-Guided High-Intensity-Focused Ultrasound With Standard (Minimally) Invasive Fibroid Treatments: Protocol for a Multicenter Randomized Controlled Trial (MYCHOICE).
JMIR research protocols ·doi:10.2196/29467

BackgroundMagnetic resonance image-guided high-intensity-focused ultrasound (MR-HIFU) is a rather new, noninvasive option for the treatment of uterine fibroids. It is safe, effective, and has a very short recovery time. However, a lack of p…

article 2018
Magnetic Resonance Imaging–Guided High-Intensity Focused Ultrasound is a Noninvasive Treatment Modality for Patients with Abdominal Wall Endometriosis
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2018.03.018

Two women (29 and 35 years of age) presented with an abdominal wall mass in close proximity to a cesarean scar. The main complaints consisted of pain at the site of the mass with catamenial exacerbations. Clinical and imaging findings were …

2016
The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
Gynecological Surgery ·doi:10.1007/s10397-015-0915-3

The FAST-EU Trial was designed to establish the effectiveness and confirm the safety of transcervical intrauterine sonography-guided radiofrequency ablation with the VizAblate™ System in the treatment of symptomatic uterine fibroids. This w…